Abstract
Purpose
The aim of this study was to evaluate the expression profiles of the relevant selectins and PDGF in schistosomiasis-associated pulmonary hypertension.
Methodology
Patients with three distinct clinical profiles were enrolled in the study: IPAH(n = 11), schistosomiasis-associated PH (Sch-PH))(n = 13), and schistosomiasis without PH (Sch) (n = 13). Healthy volunteers, were recruited as a control group(n = 13). Echocardiography was performed in all groups, and the PH patients underwent right heart catheterization. Plasma soluble adhesion molecules E- and P-Selectin, PDGF-AB, PDGF-BB were determined by ELISA.
Results
E-selectin was significantly increased in the IPAH group compared with the other groups [the control, Sch + PH and Sch groups) (p < 0.001) (Fig. 2)]. P-selectin was lower in Sch (20.2 + 8.9 × 103 pg/mL) as compared to the control, (43 16.8 × 103 pg/mL), IPAH (35.8 7.8 × 103 pg/mL), and Sch + PH (36.8 ± 15.7 × 103 pg/mL) (p = 0.005) groups. Serum PDGF-BB levels were higher in the control group (8.9 ± 4.8 × 103 pg/mL) compared with the IPAH (3.7 ± 2.17 × 103 pg/mL), Sch + PH (5.2 ± 3.7 × 103 pg/mL) and Sch (2.4 ± 1.7 × 103 pg/mL) groups (p < 0.05). PDGF-AB levels were also higher in the control group (25.6 ± 8.6 × 103 pg/mL), compared with the other three groups, being the Sch group the one with lower serum levels of this marker (11.4 ± 8.6 × 103 pg/mL) (p = 0.006).
Conclusions
In conclusion, vascular inflammation in schistosomiasis, with or without PH, is different from IPAH suggesting distinct pathophysiological mechanisms associated with the development of pulmonary hypertension.
Similar content being viewed by others
References
Chin KM, Rubin LJ (2008) Pulmonary arterial hypertension. J Am Coll Cardiol 51:1527–1538
Badesch DB, Champion HC, Sanchez MAG, Hoeper MM, Loyd JE et al (2009) Diagnosis and assessment of pulmonary hypertension. J Am Coll Cardiol 54(1):255–266
Humbert M (2008) Update in pulmonary arterial hypertension 2007. Am J Respir Crit Care Med 177:574–579. doi:10.1164/rccm.200801-029UP
Souza R, Fernandes CJ, Jardim CV (2009) Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension). Semin Respir Crit Care Med 30(4):448–457. doi:10.1055/s-0029-1233314
Lapa MS, Dias B, Jardim C, Fernandes CJC, Dourado P, Figueiredo M, Farias A, Tutsui J, Terra-Filho M, Humbert M, Souza R (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119:1518–1523
Butrous G, Ghofrani HA, Grimminger F (2008) Pulmonary vascular disease in the developing world. Circulation 118:1758–1766
Conceição MJ, Borges-Pereira J, Coura JR (2007) A thirty years follow-up study on Schistosomiasis mansoni in a community of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 102(8):1007–1009
Lambertucci JR, Serufo JC, Gerspacher-Lara R, Rayes AAM et al (2000) Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop 77:101–109
Fernandes CJCS, Jardim CVP, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R (2010) Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 56:715–720
Cahill PARE, Sitzmann JV (2001) Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 89:273–293 (2001)
Richter J (2000) Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop 77:111–131
Cichoz-Lach HCK, Stomka M, Kasztelan-Szczerbinska B (2008) Pathophysiology of portal hypertension. J Physiol Pharmacol 59(Suppl 2):231–238
Cella G, Belloto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J (2001) Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120:1226–1230
Morrel NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX-Y, Weir EK (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):s20–s31. doi:10.1016/j.jacc.2009.04.018
Graham BB, Bandeira AP, Morrell NW, Butrous G, Tuder RM (2010) Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):20s–29s
Barrier M, Meloche J, Jacob MH, Courboulin A, Provencher S, Bonnet S (2012) Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension. Cell Mol Life Sci 69(17):2805–2831. doi:10.1007/s00018-012-0950-4
Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159–165
Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herve P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M (2007) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178(1):81–88. doi:10.1164/rccm.200707-1037OC07-1037OC
Trottein F, Nutten S, Angeli V, Delerive P et al (1999) Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with NF-kappaB pathway. Eur J Immunol 29:3691–3701
Soares S, Rodrigues-Junior V, Silva DTN, Moraes-Souza H (2007) Participation of platelets in the process of fibrosis in patients with mansonic schistosomiasis. schistosomiasis. Rev Soc Bras Med Trop 40(3):321–325
Vezozzo DCP, Farias AQ, Cerri GG, da Silva LC, Carrilho FJ (2006) Assessment of portal hemodynamics by doppler ultrasound and of liver morphology in the hepatospleinc and hepatointestinal forms of Schistosomiasis mansoni. Dig Dis Sci 51:1413–1419
Hatz C, Jenkins JM, Ali QM, Abdel-Wahab MF, Cerri GG, Tanner M (1992) A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 2. Schistosoma mansoni. Acta Trop 51:15–28
Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33(4):397–406
Simmonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliot CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43–S54
Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R (2005) Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria. Vasc Pharmacol 43(3):143–147. doi:10.1016/j.vph.2005.05.004
Rather LJ, Virchow RLK, Schwalbe J (1990) A commentary on the medical writings of Rudolf Virchow: based on Schwalbe’s Virchow-Bibliographie, 1843–1901. Norman Publishing
Witters P, Freson K, Verslype C, Peerkink K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D (2008) Review article: blood platelet count number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 27:1017–1029
Eddahibi E, Humbert M, Sediame S, Chouaid C et al (2000) Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Am J Respir Crit Care Med 162:1493–1499
Andrae J, Gallini R, Betsholtz C (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22(10):1276–1312
Acknowledgments
We thank Carlos Sérgio Rocha da Silva from Pleura Laboratory and the MECOR course instructors, especially William Volmer.
Financial support
Fundação de Amparo a Pesquisa do Estado de São Paulo - FAPESP.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lapa, M., Acencio, M.M.P., Farias, A.Q. et al. Selectins and Platelet-Derived Growth Factor (PDGF) in Schistosomiasis-Associated Pulmonary Hypertension. Lung 192, 981–986 (2014). https://doi.org/10.1007/s00408-014-9643-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-014-9643-0